Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Regarding the brand new $IFUS twitter video you shared, this one,
#IFUS#cattle#Dairy#Drought#Hay Good Morning. This renewable product will end up as SGP+. Hope you enjoy video. 12 of these will be delivered today. Only plant in the world with this process. No reason for cows to starve. Any questions, call Marc 1-800-775-4130 pic.twitter.com/DUcytGPVtP
$IFUS delivering new tweet and 12 truckloads of revenue
#IFUS#cattle#Dairy#Drought#Hay Good Morning. This renewable product will end up as SGP+. Hope you enjoy video. 12 of these will be delivered today. Only plant in the world with this process. No reason for cows to starve. Any questions, call Marc 1-800-775-4130 pic.twitter.com/DUcytGPVtP
Great meeting today on a perfect Resilient acquisition. Current production with upside. Traditional play and a great price! The more we look the more we find!
Confirming per our agreement with JP Energy, there will be NO reserve split of the Common Stock until at least September 30, 2025, unless we're moving up to NYSE or NASDAQ. Stay tuned for updates about the the journey ahead! $NHMD
May want to read up on SGS who prepared the linked report ... Today, we are the nation’s leading provider of inspection, testing, verification and certification services, helping clients in virtually every sector to reduce risk and improve productivity.
$ASRE .40. I found this recent interview with Kermit Harris and Doug Hampton. It explains in depth what Astra is doing in Hesperia with the Regreen TWS and its ultimate plans. During the interview, Doug revealed that Astra has other deals in place in CA, which are likely going to be announced soon. The interview is over 30 minutes long and is with the Zero WAste Sonoma LTF Board. All interested should watch. The interview starts at 23 minutes.. You can find it here:
$SHMN .0011 SOHM Announces Its Acquisition of ABBIE, a World-Class Gene-Editing Platform Which Can Deliver Genetic Payloads Using Non-Viral Vectors SOHM, Inc. Tue, September 26, 2023 at 9:30 AM EDT In this article:
SHMN -18.1818% Watchlist
Watchlist SOHM, Inc. SOHM, Inc. CHINO HILLS, Calif., Sept. 26, 2023 (GLOBE NEWSWIRE) -- via IBN -- SOHM, Inc. (OTC PINK: SHMN), a pharmaceutical, nutraceutical and cosmeceutical company that manufactures and markets generic drugs covering numerous treatment categories, announces today that it has acquired:
ABBIE, a world-class gene-editing platform which can deliver genetic payloads using non-viral vectors.
With this acquisition, SOHM is well-positioned as a competitive player in the $5.3 billion gene-editing market in 2023. The gene-editing market is expected to grow to $10.8 billion by 2028 at a 15% CAGR. (Source: 2023, Marketsandmarkets.com.)
ABBIE uses targeted integration to insert larger DNA sequences (aka, genetic payload), including full genes, into a desired loci of the target cell’s genome. ABBIE will be able to edit genes of a large number of cell types at different stages of their life cycles, overcoming the limitations of current cell editing and cell engineering technologies.
ABBIE is currently undergoing further development to optimize expression and purification of its protein-based platform. Upon completion of development, ABBIE will become high-quality, off-the-shelf cell engineering kits. Gene-editing companies will use ABBIE kits to deliver a gene payload to a specific locus on their targeted cells.
Revenue generations can be obtained immediately through licensing and gene-editing kits slated to be released for commercialization in 3Q/4Q 2024. ABBIE is expected to reach in-human trial on or before 4Q 2025.
The global biotechnology kit market is estimated at $593 billion in 2022 and projected to grow at a 10.9% CAGR between 2023 and 2030. (Source: 2023, GrandViewResearch.com.)
ABBIE’s development is being led by David Aguilar PhD, SOHM’s COO. Dr. Aguilar has extensive experience in molecular and cellular biology, genome editing, and has been an entrepreneur in biotechnology since 2015.
“ABBIE is a platform tool that delivers genes of interest for clinical trials. Compared to other gene-editing technologies, ABBIE has achieved the same level of progress with much less R&D spending. Our strategic partnerships and capital management have enabled us to streamline development and expedite our commercialization,” says Dr. Aguilar.
ABBIE was acquired from CGA 369 for $10 million. The first payment of $6 million will be paid in 12 months from the effective date and will be a combination of $3 million cash and $3 million in restricted common stock. The remaining $4 million payment to CGA 369 will be triggered by ABBIE’s first $50 million of commercial sales.
ABBIE development will be presented at the following scientific conferences:
Apr 2024: American Association of Cancer Research, AACR 2024, in San Diego, California
May 2024: SynbioBeta 2024 in San Jose, California
------------------------------------------
About CGA 369
CGA 369 is a cutting-edge bio tech company revolutionizing the way proteins are expressed, validated and engineered, paving the way for a future of endless possibilities.
CGA 369 caters to the emerging cell engineering space by specializing in protein expression, offering state-of-the-art technologies and innovative solutions to harness the full potential of proteins. The company is driven by a dedicated team of experts combining expertise in molecular biology, genetic engineering and bioinformatics to unlock the intricate mechanisms of protein synthesis, ensuring precise and optimized expression for a wide range of applications.
To learn more about CGA 369, visit www.cga369.com
About SOHM, Inc.
SOHM, Inc. is a growing generic pharmaceutical manufacturing and marketing company with a vision of “Globalè Prospèro” that aims to build continuous growth. SOHM manufacturing and marketing targets rapidly growing healthcare segments such as nutraceuticals, cosmeceuticals and other major therapeutic segments. SOHM is headquartered in North America with manufacturing alliances in India and strategic alliances with U.S. manufacturing facilities. Although SOHM’s generic pharmaceuticals are exported globally and were introduced to the USA in early 2013, SOHM continues its focus on distribution to emerging markets in Africa, Latin America and Southeast Asia.
To learn more about SOHM, Inc., visit www.SOHM.com.
Safe Harbor Statement:
This news release contains “forward-looking statements,” which are statements that are not purely historical and include any statements regarding beliefs, plans, expectations or intentions regarding the future. Such forward-looking statements include, among other things, the development, costs and results of new business opportunities. Actual results could differ from those projected in any forward-looking statements due to numerous factors. Such factors include, among others, the inherent uncertainties associated with new projects and development-stage companies. These forward-looking statements are made as of the date of this news release, and we assume no obligation to update the forward-looking statements or to update the reasons why actual results could differ from those projected in the forward-looking statements. Although we believe that any beliefs, plans, expectations and intentions contained in this press release are reasonable, there can be no assurance that any such beliefs, plans, expectations or intentions will prove to be accurate. Investors should consult all of the information set forth herein and should also refer to the risk factors disclosure outlined in our annual report for the most recent fiscal year and our quarterly reports uploaded from time to time on OTCMarkets.com.
BLTH & SGII:NASDAQ Merger News of SEC Registration...
This is more solid news of the BLTH merger into SGII:NASDAQ to actually be happening:
Seaport Global Acquisition II Corp. and American Battery Materials, Inc. Announce Initial Filing of Registration Statement on Form S-4 in Connection With Their Proposed Business Combination
~ Registration Statement on File with the SEC Marks Significant Step Towards Achieving Necessary Approvals for Merger Completion ~
~ Filing Milestone Serves as a Joint Effort on the Heels of ABM’s Recently Announced Commitment to $120 Million Merger ~
NEW YORK and GREENWICH, Conn., Sept. 26, 2023 (GLOBE NEWSWIRE) -- Seaport Global Acquisition II Corp. (NASDAQ: SGII) (“SGII”), a publicly-listed special purpose acquisition company, and American Battery Materials, Inc. (OTC Pink: BLTH) (“ABM” or the “Company”), an environmentally responsible minerals exploration and development company focused on direct lithium extraction and other critical minerals for the global energy transition, announced today SGII filed the initial Registration Statement on Form S-4 (the "Registration Statement") with the U.S. Securities and Exchange Commission (“SEC”) as a necessary and critical step towards merger completion.
The Registration Statement contains a preliminary proxy statement/prospectus in connection with the previously announced proposed business combination between SGII and ABM (the “Proposed Business Combination”). While the Registration Statement has not yet become effective and the information contained therein is subject to change, it provides important information about SGII and ABM, as well as the Proposed Business Combination.
Stephen Smith, Chief Executive Officer and Chairman of SGII commented: “The filing of the Registration Statement marks an important milestone for us in the process to uplist American Battery Materials to the Nasdaq. We remain confident that ABM is primed and positioned to be a leader in the important lithium supply chain here in the U.S., with its planned use of direct lithium extraction leading the way for an environmentally friendly, cost-effective, and highly scalable business.”
David Graber, Chairman and Co-Chief Executive Officer of ABM added: “Since we first announced the business combination with Seaport back in June, ABM has continued to make great progress. We have significantly expanded our mining claims in the Lisbon Valley of Utah; produced an updated technical report; and, readied ourselves to commence drilling. Further, the demand for lithium continues to far outpace supply. We are excited to have the Registration Statement filed and move forward with the proposed merger, which will be a defining moment for ABM and its shareholders. ABM remains uniquely positioned to capitalize on shifting market dynamics reflecting ongoing electrification trends across the globe, and our planned uplisting to the Nasdaq should enable us to advance our lithium activities to critical mass.”
Proposed Business Combination
On June 2, 2023, SGII and ABM announced the signing of a definitive merger agreement for the Proposed Business Combination that will result in ABM becoming a wholly owned subsidiary of SGII. Following the closing of the Proposed Business Combination, it is expected that the combined company will (i) be renamed “American Battery Materials Holdings”; (ii) have its common stock and warrants listed on the Nasdaq Global Market (“Nasdaq”); and, (iii) be led by the existing management team of ABM in a seamless transition of power.
About Seaport Global Acquisition II Corp.
Seaport Global Acquisition II Corp. is a blank check company formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses.
About American Battery Materials, Inc.
American Battery Materials, Inc., (OTC Pink: BLTH), is a U.S.-based environmentally responsible critical minerals exploration and development company focused on Direct Lithium Extraction (DLE) as well as other minerals for refining, processing, and distribution to support the country’s urgent critical minerals need to bolster long-term energy transition and the electrification of the US domestic and global economy. For more information, visit www.americanbatterymaterials.com. The information contained on, or that may be accessed through, this website is not incorporated by reference into, and is not a part of, this communication.
To receive American Battery Materials, Inc. company updates via email, visit the Contact page of our web site, www.americanbatterymaterials.com/contact.
Additional Information about the Proposed Business Combination and Where to Find It In connection with the Proposed Business Combination, SGII has filed the Registration Statement which includes a preliminary proxy statement/prospectus with the U.S. Securities and Exchange Commission (“SEC”). SGII’s stockholders and other interested persons are advised to read the Registration Statement, as well as other documents filed with the SEC in connection with the Proposed Business Combination, as these materials will contain important information about ABM, SGII and the Proposed Business Combination. When available, the Registration Statement will be mailed to stockholders of SGII as of a record date to be established for voting on, among other things, the Proposed Business Combination. Stockholders will also be able to obtain copies of the Registration Statement and other documents filed with the SEC that will be incorporated by reference therein, without charge, once available, at the SEC's website at www.sec.gov. The information contained on, or that may be accessed through, the websites referenced in this communication is not incorporated by reference into, and is not a part of, this communication.
Participants in Solicitation SGII and its respective directors and executive officers may be deemed participants in the solicitation of proxies from SGII’s stockholders in connection with the Proposed Business Combination. SGII’s and ABM’s stockholders and other interested persons may obtain, without charge, more detailed information regarding the directors and officers of SGII and ABM in SGII's Annual Report on Form 10-K filed with the SEC on April 4, 2023 and ABM’s Annual Report on Form 10-K filed with the SEC on April 21, 2023. Information regarding the persons who may, under SEC rules, be deemed participants in the solicitation of proxies to SGII stockholders in connection with the Proposed Business Combination is set forth in the Registration Statement. Additional information regarding the interests of participants in the solicitation of proxies in connection with the Proposed Business Combination is included in the Registration Statement that SGII has been filed with the SEC.
Forward Looking Statements This press release includes certain statements that are not historical facts but are forward-looking statements for purposes of the safe harbor provisions under the United States Private Securities Litigation Reform Act of 1995. Forward-looking statements generally are accompanied by words such as "believe," "may," "will," "estimate," "continue," "anticipate," "intend," "expect," "should," "would," "plan," "predict," "potential," "seem," "seek," "future," "outlook," and similar expressions that predict or indicate future events or trends or that are not statements of historical matters. All statements, other than statements of present or historical fact included in this communication, regarding SGII’s Proposed Business Combination with ABM, SGII's ability to consummate the transaction, the benefits of the transaction and the combined company's future financial performance, as well as the combined company's strategy, future operations, estimated financial position, estimated revenues and losses, projected costs, prospects, plans and objectives of management are forward-looking statements. These statements are based on various assumptions, whether or not identified in this communication, and on the current expectations of the respective management of SGII and ABM and are not predictions of actual performance. These forward-looking statements are provided for illustrative purposes only and are not intended to serve as, and must not be relied on as, a guarantee, an assurance, a prediction or a definitive statement of fact or probability. Actual events and circumstances are difficult or impossible to predict and will differ from assumptions. Many actual events and circumstances are beyond the control of SGII or ABM. Potential risks and uncertainties that could cause the actual results to differ materially from those expressed or implied by forward-looking statements include, but are not limited to, changes in domestic and foreign business, market, financial, political and legal conditions; the inability of the parties to successfully or timely consummate the business combination, including the risk that any regulatory approvals are not obtained, are delayed or are subject to unanticipated conditions that could adversely affect the combined company or the expected benefits of the business combination or that the approval of the stockholders of SGII or ABM is not obtained; failure to realize the anticipated benefits of business combination; risk relating to the uncertainty of the projected financial information with respect to ABM; the amount of redemption requests made by SGII's stockholders; the overall level of consumer demand for lithium; general economic conditions and other factors affecting; disruption and volatility in the global currency, capital, and credit markets; ABM's ability to implement its business and growth strategy; changes in governmental regulation, ABM's exposure to litigation claims and other loss contingencies; disruptions and other impacts to ABM’s business, as a result of the COVID-19 pandemic and government actions and restrictive measures implemented in response, and as a result of the proposed transaction; ABM's ability to comply with environmental regulations; competitive pressures from many sources, including those, having more experience and better financing; changes in technology that adversely affect demand for lithium compounds; the impact that global climate change trends may have on ABM and its potential mining operations; any breaches of, or interruptions in, SGII's or ABM’s information systems; fluctuations in the price, availability and quality of electricity and other raw materials and contracted products as well as foreign currency fluctuations; changes in tax laws and liabilities, tariffs, legal, regulatory, political and economic risks.
More information on potential factors that could affect SGII’s or ABM's financial results is included from time to time in SGII's and ABM’s public reports filed with the SEC, including their Annual Reports on Form 10-K, Quarterly Reports on Form 10-Q, and Current Reports on Form 8-K as well as the Registration Statement that SGII has filed with the SEC in connection with SGII’s solicitation of proxies for the meeting of stockholders to be held to approve, among other things, the Proposed Business Combination. If any of these risks materialize or SGII's or ABM's assumptions prove incorrect, actual results could differ materially from the results implied by these forward-looking statements. There may be additional risks that neither SGII nor ABM presently know, or that SGII and ABM currently believe are immaterial, that could also cause actual results to differ from those contained in the forward-looking statements. In addition, forward-looking statements reflect SGII's and ABM's expectations, plans or forecasts of future events and views as of the date of this communication. SGII and ABM anticipate that subsequent events and developments will cause their assessments to change. However, while SGII and ABM may elect to update these forward-looking statements at some point in the future, SGII and ABM specifically disclaim any obligation to do so, except as required by law. These forward-looking statements should not be relied upon as representing SGII's or ABM's assessments as of any date subsequent to the date of this communication. Accordingly, undue reliance should not be placed upon the forward-looking statements.
No Offer or Solicitation This communication shall neither constitute an offer to sell or the solicitation of an offer to buy any securities, nor shall there be any sale of securities in any jurisdiction in which the offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of any such jurisdiction.
Food for thought and I remind myself... With the DTC being less than 20 million along with the toxic note being paid in full, we could see a nice move when/if the company finalizes this spinoff mentioned in the recent press. The ratio still to be determined along…
News 
Market Data 
Discover 
